Literature DB >> 17220401

Gamma interferon loaded onto albumin nanoparticles: in vitro and in vivo activities against Brucella abortus.

S Segura1, C Gamazo, J M Irache, S Espuelas.   

Abstract

The aim of this study was to evaluate the activity of gamma interferon (IFN-gamma) when it was either adsorbed onto or loaded into albumin nanoparticles. Brucella abortus-infected macrophages and infected BALB/c mice were selected as the models for testing of the therapeutic potentials of these cytokine delivery systems, in view of the well-established role of IFN-gamma-activated macrophages for the control of Brucella sp. infections. Whereas the encapsulation of IFN-gamma inside the matrix of nanoparticles completely abrogated its activity, adsorbed IFN-gamma increased by 0.75 log unit the bactericidal effect induced by RAW macrophages activated with free IFN-gamma, along with a higher level of production of nitric oxide. In infected BALB/c-mice, IFN-gamma adsorbed onto nanoparticles was also more active than free cytokine in reducing the number of bacteria in the spleens, and the effect was mediated by an increased ratio of IFN-gamma-secreting (Th1) to interleukin-4-secreting (Th2) cells. Overall, albumin nanoparticles would be suitable as carriers that target IFN-gamma to macrophages and, thus, potentiate their therapeutic activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17220401      PMCID: PMC1855480          DOI: 10.1128/AAC.00890-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  33 in total

Review 1.  Targeting to macrophages: role of physicochemical properties of particulate carriers--liposomes and microspheres--on the phagocytosis by macrophages.

Authors:  Fakhrul Ahsan; Isabel P Rivas; Mansoor A Khan; Ana I Torres Suarez
Journal:  J Control Release       Date:  2002-02-19       Impact factor: 9.776

Review 2.  Mechanisms of type-I- and type-II-interferon-mediated signalling.

Authors:  Leonidas C Platanias
Journal:  Nat Rev Immunol       Date:  2005-05       Impact factor: 53.106

3.  Immune control of Brucella abortus 2308 infections in BALB/c mice.

Authors:  E A Murphy; M Parent; J Sathiyaseelan; X Jiang; C L Baldwin
Journal:  FEMS Immunol Med Microbiol       Date:  2001-12

4.  IL-12 induction by a TH1-inducing adjuvant in vivo: dendritic cell subsets and regulation by IL-10.

Authors:  L Y Huang; C Reis e Sousa; Y Itoh; J Inman; D E Scott
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

5.  Potential of albumin nanoparticles as carriers for interferon gamma.

Authors:  Sara Segura; Socorro Espuelas; María Jesús Renedo; Juan Manuel Irache
Journal:  Drug Dev Ind Pharm       Date:  2005-03       Impact factor: 3.225

6.  Gentamicin-loaded microspheres for treatment of experimental Brucella abortus infection in mice.

Authors:  Sandra Prior; Bruno Gander; Juan M Irache; Carlos Gamazo
Journal:  J Antimicrob Chemother       Date:  2005-05-09       Impact factor: 5.790

7.  Interferon-gamma is crucial for surviving a Brucella abortus infection in both resistant C57BL/6 and susceptible BALB/c mice.

Authors:  E A Murphy; J Sathiyaseelan; M A Parent; B Zou; C L Baldwin
Journal:  Immunology       Date:  2001-08       Impact factor: 7.397

8.  Endogenous gamma interferon mediates resistance to Brucella abortus infection.

Authors:  Y Zhan; C Cheers
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

Review 9.  The role of interferon-gamma in the treatment of visceral and diffuse cutaneous leishmaniasis.

Authors:  R Badaro; W D Johnson
Journal:  J Infect Dis       Date:  1993-03       Impact factor: 5.226

10.  Effects of cytokines on intracellular growth of Brucella abortus.

Authors:  X Jiang; C L Baldwin
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

View more
  6 in total

Review 1.  Nanoparticulate systems for growth factor delivery.

Authors:  Sufeng Zhang; Hasan Uludağ
Journal:  Pharm Res       Date:  2009-05-05       Impact factor: 4.200

Review 2.  Particle-mediated delivery of cytokines for immunotherapy.

Authors:  David A Christian; Christopher A Hunter
Journal:  Immunotherapy       Date:  2012-04       Impact factor: 4.196

3.  Preparation of BMP-2 containing bovine serum albumin (BSA) nanoparticles stabilized by polymer coating.

Authors:  Guilin Wang; Kevin Siggers; Sufeng Zhang; Hongxing Jiang; Zhenghe Xu; Ronald F Zernicke; John Matyas; Hasan Uludağ
Journal:  Pharm Res       Date:  2008-08-15       Impact factor: 4.200

4.  Protein-Based Nanoparticle Preparation via Nanoprecipitation Method.

Authors:  Mohamad Tarhini; Ihsane Benlyamani; Selim Hamdani; Géraldine Agusti; Hatem Fessi; Hélène Greige-Gerges; Abderrazzak Bentaher; Abdelhamid Elaissari
Journal:  Materials (Basel)       Date:  2018-03-07       Impact factor: 3.623

Review 5.  Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion.

Authors:  Flávia Castro; Ana Patrícia Cardoso; Raquel Madeira Gonçalves; Karine Serre; Maria José Oliveira
Journal:  Front Immunol       Date:  2018-05-04       Impact factor: 7.561

Review 6.  Recent advances and challenges of repurposing nanoparticle-based drug delivery systems to enhance cancer immunotherapy.

Authors:  Seungho Lim; Jooho Park; Man Kyu Shim; Wooram Um; Hong Yeol Yoon; Ju Hee Ryu; Dong-Kwon Lim; Kwangmeyung Kim
Journal:  Theranostics       Date:  2019-10-16       Impact factor: 11.556

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.